CrushSCI.com
149.9Average days
144Median days
55Fastest days
235Longest days
582025 publications

Paper Review Records

All Paper Review Records

15 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

226 days

Potential cardioprotective mechanisms of Bawu Junzi decoction in myocardial infarction: Identification of CYP1B1 and ALDH2 as key mediators

Authors
Fengtong Li; Jingmei ChaiShow moreShow less
Affiliations
Yanbian University, Yanji 133000, China; Department of Basic TCM Teaching and Research, Yanbian University Medical School, Yanji 133000, ChinaShow moreShow less
Source PDF DOI Publisher page
166 days

A comparative bibliometric analysis of natural product-based combination therapies in lung cancer: Insights into analytical strategies and translational challenges

Authors
Chuanlong Zhang; Mengqi Gao; Xiyuan Zhang; Chang Che; Xuanye Cao; Lin Zhang; Ziheng WangShow moreShow less
Affiliations
Department of Traditional Chinese Medicine, Beijing Friendship Hospital, Capital Medical University, Beijing, China; Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing, China; Guang’anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China; Department of Clinical and Translational Research Center, Affiliated Hospital of Nantong University, Nantong, Jiangsu, China; The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Department of Epidemiology and Preventive Medicine, The School of Public Health and Preventive Medicine, Monash University, Clayton, Australia; Centre for Precision Medicine Research and Training, Faculty of Health Sciences, University of Macau, Macao Special Administrative Region of ChinaShow moreShow less
Source PDF DOI Publisher page
94 days

Paeoniflorin alleviates sepsis-induced liver injury: Insights from integrative transcriptomic and metabolomic analysis

Authors
Li Li; Xinyu Gu; Hui Wang; Yingru Liu; Lijun Xu; Yanwei Cheng; Lu WangShow moreShow less
Affiliations
Department of Emergency, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, Zhengzhou, Henan 450052, China; Henan Key Laboratory of Cancer Epigenetics, Cancer Institute, The First Affiliated Hospital, and College of Clinical Medicine of Henan University of Science and Technology, Luoyang, Henan 471003, China; Department of Infectious Diseases, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450052, China; Department of Thyroid Surgery, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, Zhengzhou, Henan 450052, ChinaShow moreShow less
Source PDF DOI Publisher page
235 days

In vitro evidence of Piperlongumine as a potential radiosensitizer in cervical cancer cells

Authors
Li Shan; Ye Lu; Xiaoli Zhu; Xu ChengShow moreShow less
Affiliations
Department of Radiation Oncology, Taicang Hospital Affiliated to Soochow University (the First People’s Hospital of Taicang), Taicang, Suzhou 215400, China; Department of Geriatrics, Qingpu Branch of Zhongshan Hospital Affiliated to Fudan University, Shanghai 201799, ChinaShow moreShow less
Source PDF DOI Publisher page
199 days

Smilax glabra Roxb. alleviates gout through targeting FOS and CD40LG: Insights from multi-omics integration

Authors
Hui Zhou; Xiansheng Tian; Kaijie YeShow moreShow less
Affiliations
Department of Traditional Chinese Medicine, The Eighth Affiliated Hospital, Sun Yat-sen University, Shenzhen, 518033, China; Institute of Neuroscience, School of Medicine, Xiamen University, Xiamen 361102, China; Department of Anesthesiology, The First Affiliated Hospital of Xiamen University, Xiamen 361003, China; Department of Laboratory Medicine, The Eighth Affiliated Hospital, Sun Yat-Sen University, Shenzhen 518033, ChinaShow moreShow less
Source PDF DOI Publisher page
192 days

Exploitation of Ziziphus lotus fruit as a functional culture medium: Impact of yeast fermentation on bioactive composition, antioxidant activity, and In Silico evaluation

Authors
Chemes Elhouda Messaad; Hani Belhadj; Saad Mebrek; Mohamed Abdesselem Dems; Chawki Bensouici; Khalid Bouhedjar; Mustafa Abdullah Yilmaz; Oguz Cakir; Ayomide Victor Atoki; Mohammed MessaoudiShow moreShow less
Affiliations
Laboratory of Biodiversity and Biotechnological Techniques for Plant Resources Valorization, University of M’sila, University Pole, Road Bordj Bou Arreridj, M’sila, 28000, Algeria; Laboratory of Applied Microbiology, Department of Microbiology, Faculty of Nature and Life Sciences, Ferhat Abbas University-Setif 1, Setif 19000, Algeria; Immunoengineering Team, Biotechnology and Health Division, Biotechnology Research Center, Ali Mendjeli Nouvelle Ville UV 03, Constantine BP E73, Algeria; Simulation, Modeling and Data Management Team, Industrial Biotechnology Division, Biotechnology Research Center, Ali Mendjeli Nouvelle Ville UV 03, Constantine BP E73, Algeria; Natural Substances, Applied Pharmacology and Toxicology Team, Biotechnology and Health Division, Biotechnology Research Center, Ali Mendjeli Nouvelle Ville UV 03, Constantine BP E73, Algeria; Dicle University Science and Technology Research and Application Center, Diyarbakir 21280, Turkey; Dicle University, Faculty of Pharmacy, Department of Analytical Chemistry, Diyarbakir 21280, Turkey; Dicle University, Faculty of Health Sciences, Department of Nutrition and Dietetics, Diyarbakir 21280, Turkey; Department of Biochemistry, Kampala International Universit, Ishaka, Bushenyi, Uganda; Department of Biochemistry, Federal University of Agriculture and Development Studies, Iragbiji, Nigeria; Laboratory of Research on Bioactive Products and Biomass Valorization, Department of Chemistry, Higher Normal School of Kouba (ENS), P.O. Box 92, Vieux Kouba, Algiers 16308, Algeria; Laboratory N—Body and Structure of Matter, Department of Chemistry, Higher Normal School of Kouba (ENS), P.O. Box 92, Vieux Kouba, Algiers 16308, AlgeriaShow moreShow less
Source PDF DOI Publisher page

FAQ

How long does Current Pharmaceutical Analysis take to review a manuscript?

As of 2026-11-19, CrushSCI has 15 complete review records for Current Pharmaceutical Analysis. The fastest paper went from submission to acceptance in 55 days (In silico discovery of novel benzenesulfonamide-tetrahydropyrimidine hybrids as dual target inhibitors of EGFR and thymidylate synthase, received 2026-06-11, accepted 2026-08-05); the slowest took 235 days. The average is 149.9 days and the median is 144 days.

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

We will reply within 30 minutes.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review59.6 days

Median65 days

Contact CrushSCI

Contact CrushSCI

Leave your email address to discuss academic polishing, structural refinement, or one-to-one guidance.

We will reply within 30 minutes.

Selected service: Academic Consulting Service

Leave your email address

Or email us directly at leader@crushsci.com

Enter your email address so we can reply. Your details will remain private.